By David Hadden, President and Founder of Pro-ficiency
Clinical trial costs are trending upward, driven by a variety of factors, such as increasing trial complexity and rising travel costs for training, meetings and monitoring. While some of these factors are largely fixed, costs can be controlled by focusing on areas that lie well within the sponsors’ and research sites’ control.
And much of that focus should be on things that can lead to errors, which can significantly increase the time needed to complete a clinical trial, require work to be re-done and require corrective actions, such as staff re-training, that also add to costs.
But three simple steps can help clinical researchers reduce both errors and costs during studies. The trick is to focus on those parts of clinical trial preparation and conduct that can most affect key drivers of cost increases.